Medical Care
Global Alzheimer’s Disease Therapeutics and Diagnostics Market Research Report 2024
- Jan 26, 24
- ID: 27121
- Pages: 70
- Figures: 143
- Views: 59
The global Alzheimer’s Disease Therapeutics and Diagnostics market was valued at US$ 6596.5 million in 2023 and is anticipated to reach US$ 8589.1 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alzheimer’s Disease Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer’s Disease Therapeutics and Diagnostics.
Report Scope
The Alzheimer’s Disease Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer’s Disease Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer’s Disease Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Eisai
Novartis
Forest Laboratories
TauRx Therapeutics
AC Immune
Johnson & Johnson.
H. Lundbeck
Segment by Type
Diagnostics
Treatment
Segment by Application
Marketed Drugs
Pipeline Drugs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer’s Disease Therapeutics and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alzheimer’s Disease Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer’s Disease Therapeutics and Diagnostics.
Report Scope
The Alzheimer’s Disease Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer’s Disease Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer’s Disease Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Eisai
Novartis
Forest Laboratories
TauRx Therapeutics
AC Immune
Johnson & Johnson.
H. Lundbeck
Segment by Type
Diagnostics
Treatment
Segment by Application
Marketed Drugs
Pipeline Drugs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer’s Disease Therapeutics and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Marketed Drugs
1.3.3 Pipeline Drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Perspective (2019-2030)
2.2 Alzheimer’s Disease Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Dynamics
2.3.1 Alzheimer’s Disease Therapeutics and Diagnostics Industry Trends
2.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
2.3.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
2.3.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Disease Therapeutics and Diagnostics Revenue
3.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2023
3.5 Alzheimer’s Disease Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
6.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
6.4 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
7.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
9.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.1.4 Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.2.4 Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.3.4 Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Forest Laboratories
11.4.1 Forest Laboratories Company Detail
11.4.2 Forest Laboratories Business Overview
11.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.4.4 Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.4.5 Forest Laboratories Recent Development
11.5 TauRx Therapeutics
11.5.1 TauRx Therapeutics Company Detail
11.5.2 TauRx Therapeutics Business Overview
11.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.5.4 TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.5.5 TauRx Therapeutics Recent Development
11.6 AC Immune
11.6.1 AC Immune Company Detail
11.6.2 AC Immune Business Overview
11.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.6.4 AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.6.5 AC Immune Recent Development
11.7 Johnson & Johnson.
11.7.1 Johnson & Johnson. Company Detail
11.7.2 Johnson & Johnson. Business Overview
11.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.7.4 Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.7.5 Johnson & Johnson. Recent Development
11.8 H. Lundbeck
11.8.1 H. Lundbeck Company Detail
11.8.2 H. Lundbeck Business Overview
11.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.8.4 H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.8.5 H. Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Marketed Drugs
1.3.3 Pipeline Drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Perspective (2019-2030)
2.2 Alzheimer’s Disease Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Dynamics
2.3.1 Alzheimer’s Disease Therapeutics and Diagnostics Industry Trends
2.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
2.3.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
2.3.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Disease Therapeutics and Diagnostics Revenue
3.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2023
3.5 Alzheimer’s Disease Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
6.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
6.4 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
7.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
9.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.1.4 Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.2.4 Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.3.4 Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Forest Laboratories
11.4.1 Forest Laboratories Company Detail
11.4.2 Forest Laboratories Business Overview
11.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.4.4 Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.4.5 Forest Laboratories Recent Development
11.5 TauRx Therapeutics
11.5.1 TauRx Therapeutics Company Detail
11.5.2 TauRx Therapeutics Business Overview
11.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.5.4 TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.5.5 TauRx Therapeutics Recent Development
11.6 AC Immune
11.6.1 AC Immune Company Detail
11.6.2 AC Immune Business Overview
11.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.6.4 AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.6.5 AC Immune Recent Development
11.7 Johnson & Johnson.
11.7.1 Johnson & Johnson. Company Detail
11.7.2 Johnson & Johnson. Business Overview
11.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.7.4 Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.7.5 Johnson & Johnson. Recent Development
11.8 H. Lundbeck
11.8.1 H. Lundbeck Company Detail
11.8.2 H. Lundbeck Business Overview
11.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Introduction
11.8.4 H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
11.8.5 H. Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnostics
Table 3. Key Players of Treatment
Table 4. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2019-2024)
Table 8. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2025-2030)
Table 10. Alzheimer’s Disease Therapeutics and Diagnostics Market Trends
Table 11. Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
Table 12. Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
Table 13. Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
Table 14. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2023)
Table 17. Ranking of Global Top Alzheimer’s Disease Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
Table 21. Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 49. Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Eisai Company Detail
Table 52. Eisai Business Overview
Table 53. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 54. Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Eisai Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 59. Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Forest Laboratories Company Detail
Table 62. Forest Laboratories Business Overview
Table 63. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 64. Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Forest Laboratories Recent Development
Table 66. TauRx Therapeutics Company Detail
Table 67. TauRx Therapeutics Business Overview
Table 68. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 69. TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 70. TauRx Therapeutics Recent Development
Table 71. AC Immune Company Detail
Table 72. AC Immune Business Overview
Table 73. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 74. AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 75. AC Immune Recent Development
Table 76. Johnson & Johnson. Company Detail
Table 77. Johnson & Johnson. Business Overview
Table 78. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 79. Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Johnson & Johnson. Recent Development
Table 81. H. Lundbeck Company Detail
Table 82. H. Lundbeck Business Overview
Table 83. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 84. H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 85. H. Lundbeck Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Diagnostics Features
Figure 4. Treatment Features
Figure 5. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Marketed Drugs Case Studies
Figure 8. Pipeline Drugs Case Studies
Figure 9. Alzheimer’s Disease Therapeutics and Diagnostics Report Years Considered
Figure 10. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030
Figure 13. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players in 2023
Figure 14. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2023
Figure 16. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 18. United States Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 22. Germany Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2019-2030)
Figure 30. China Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 38. Mexico Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 42. Turkey Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 45. Eisai Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 47. Forest Laboratories Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 48. TauRx Therapeutics Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 49. AC Immune Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 50. Johnson & Johnson. Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 51. H. Lundbeck Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnostics
Table 3. Key Players of Treatment
Table 4. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2019-2024)
Table 8. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2025-2030)
Table 10. Alzheimer’s Disease Therapeutics and Diagnostics Market Trends
Table 11. Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
Table 12. Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
Table 13. Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
Table 14. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2023)
Table 17. Ranking of Global Top Alzheimer’s Disease Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
Table 21. Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 49. Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Eisai Company Detail
Table 52. Eisai Business Overview
Table 53. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 54. Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Eisai Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 59. Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Forest Laboratories Company Detail
Table 62. Forest Laboratories Business Overview
Table 63. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 64. Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Forest Laboratories Recent Development
Table 66. TauRx Therapeutics Company Detail
Table 67. TauRx Therapeutics Business Overview
Table 68. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 69. TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 70. TauRx Therapeutics Recent Development
Table 71. AC Immune Company Detail
Table 72. AC Immune Business Overview
Table 73. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 74. AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 75. AC Immune Recent Development
Table 76. Johnson & Johnson. Company Detail
Table 77. Johnson & Johnson. Business Overview
Table 78. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 79. Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Johnson & Johnson. Recent Development
Table 81. H. Lundbeck Company Detail
Table 82. H. Lundbeck Business Overview
Table 83. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Product
Table 84. H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 85. H. Lundbeck Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Diagnostics Features
Figure 4. Treatment Features
Figure 5. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Marketed Drugs Case Studies
Figure 8. Pipeline Drugs Case Studies
Figure 9. Alzheimer’s Disease Therapeutics and Diagnostics Report Years Considered
Figure 10. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030
Figure 13. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players in 2023
Figure 14. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2023
Figure 16. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 18. United States Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 22. Germany Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2019-2030)
Figure 30. China Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 38. Mexico Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 42. Turkey Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 45. Eisai Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 47. Forest Laboratories Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 48. TauRx Therapeutics Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 49. AC Immune Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 50. Johnson & Johnson. Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 51. H. Lundbeck Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232